4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-058197
Chief Financial Officer sold 30,000 shares at an average $49.16 ($1,474,705)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-09 | Exercise or conversion : show line 1 in the form | +30,000 | $6.32 | $189,600 | 31,000 | D |
| 2020-11-09 | Sale : show line 2 in the form | −17,151 | $48.67 | $834,739 | 13,849 | D |
| 2020-11-09 | Sale : show line 3 in the form | −11,089 | $49.63 | $550,347 | 2,760 | D |
| 2020-11-09 | Sale : show line 4 in the form | −1,760 | $50.92 | $89,619 | 1,000 | D |
| Open-market sales · 30,000 sh · avg $49.16 · $1,474,705 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-09 | Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) | −30,000 | 520,000 | D |
Loading xslF345X03/doc4.xml…